Background: Few studies have addressed the risk of nutritional iron overexposure in infancy. We previously found that
Introduction
Iron is indispensable for neurodevelopment, and iron deficiency anemia, if present in infancy, can have long-term adverse neurocognitive effects (1, 2) . Despite the low prevalence of iron deficiency anemia (<10%) in many developed countries, prophylactic iron (supplements and fortified formula) is commonly given to infants aged >4-6 mo without a screening test for iron status (3, 4) . Specifically, in the United States, daily iron supplementation (1 mg/kg) is recommended for breastfed infants from 6 to 12 mo, and most infant formulas contain 10-12 mg iron/L, which is 25-60 times the iron content in mature breast milk (0.2-0.4 mg/L) (5) . However, the results from a study with healthy term infants suggested that a formula containing 1.6 mg iron/L was sufficient to achieve satisfactory iron status at age 6 mo (6) . Iron absorption in breastfed infants was shown to be in proportion to dietary iron intake during the first 6-9 mo (7), although corresponding data in formula-fed infants are lacking. Therefore, dietary iron overexposure may impose a risk of iron overload in infants, particularly in infants who are iron-replete (8) (9) (10) . Several studies have reported deleterious effects of oral iron supplementation on growth and infection in iron-replete infants from underdeveloped countries (11) (12) (13) and in infants from high-income countries (14) .
Given the pro-oxidant property of iron and the relatively low antioxidant defense of the developing brain, there is growing concern over the neurological effects of iron overexposure in infancy (8) . In a follow-up study, Lozoff et al. (15) found that iron-replete infants (6-mo hemoglobin > 12.8 g/dL) who received an iron-fortified formula (12.7 mg/L) at 6-12 mo had poorer cognitive development at age 10 y compared with infants who received a low-iron formula (2.3 mg/L). Several categories of cognition that are affected by iron fortification such as spatial memory, visual perception, and visual-motor integration require the participation of the hippocampus (16) (17) (18) . The formation of spatial memory and spatial navigation relies on the function of the hippocampus (19) . High iron supplementation (150 μg/d) of suckling mice has been shown to compromise hippocampal-dependent spatial learning and memory and to alter plasma and hepatic metabolites that are associated with amino acid and energy metabolism (20) . Unfortunately, the hippocampal iron content and metabolomic profile were not analyzed in that study.
Using a nursing piglet model, we found that iron oversupplementation notably increased iron load in both the liver (a 39-fold increase) and the hippocampus (a 1.3-fold increase), the only tissues analyzed, in comparison with the unsupplemented group (21) . This observation suggests that the developing brain is susceptible to iron infiltration. Surprisingly, iron-overloaded piglets showed a diminished preference for social novelty by spending equal amounts of time socializing with both familiar and unfamiliar pigs. Pigs are social animals, and normally spend more time investigating an unfamiliar pig (social novelty) than a familiar one (21) . Such impairment of social recognition, however, was absent in iron-replete (not overloaded) piglets and piglets with systemic iron deficiency but a normal hippocampal iron content. Burgeoning evidence underscores the critical importance of the hippocampus in social memory (22, 23) . For example, patients with hippocampal lesions displayed shorter retention time of social memory in a face-recognition task (23) . In a mouse model, dysfunction of CA2 pyramidal neurons in the hippocampus rendered indiscriminate social exploration of familiar and novel conspecifics (22) , the same behavioral phenotype as observed in iron-overloaded piglets in our previous study (21) .
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to determine the global impact of iron overload on the intermediary metabolism of the developing hippocampus in nursing piglets.
Methods

Experimental design
The study was approved by the Institutional Animal Care and Use Committee at University of California, Davis. Twenty-four Hampshire × Yorkshire crossbreed piglets [body weight (BW) at birth > 1 kg, 12 male and 12 female piglets] were stratified by birth BW, sex, and litter, and randomly assigned to 1 of 4 treatments at birth: 1) an unsupplemented group (NI); 2) an iron-replete group (control), given i.m. injection of iron dextran (100 mg iron) on postnatal day (PD) 2; 3) a moderate iron group, given a ferrous sulfate supplement (Silarx Pharmaceuticals, Inc.) at 10 mg iron/(d · kg BW); and 4) a high iron (HI) group, given a ferrous sulfate supplement at 50 mg iron/(d · kg BW) from PD2 to 21. The ferrous sulfate solution was orally administered using a syringe with the assistance of 2 research personnel. The piglets were nursed by their sows throughout the study. The likelihood that piglets consumed the sow diet was minimal based on our daily observations and the absence of dietary particles in the stomach during necropsy. The piglets were killed on PD22 to harvest tissue samples. The results for hepatic and hippocampal iron contents; hippocampal lipid peroxidation; mRNA expression of iron regulatory proteins in duodenal mucosa, liver, and hippocampus; and sociability tests for all 4 treatment groups were reported in Ji et al. (21) . Hippocampal and liver tissues were collected from the same piglets in the HI and NI groups and were further analyzed for untargeted metabolomics, mRNA and protein expression and enzyme activity of xanthine oxidase (XO), uric acid concentration (hippocampus only), and protein expression of myelin basic protein (MBP) (hippocampus only).
Untargeted metabolomics analysis
The analysis detected primary metabolites including carbohydrates, sugar phosphates, amino acids, hydroxyl acids, free fatty acids, purines, pyrimidines, and aromatic compounds. In this project, we chose to use a GC-MS approach because of its high sensitivity and ability to detect a broad range of metabolites. The analysis was performed by the NIH West Coast Metabolomics Center using GC (Agilent 6890) coupled with time-of-flight MS (Leco Pegasus IV). Metabolite extraction followed a previously described procedure (26) . Briefly, the tissue samples (∼10 mg) were homogenized in 1 mL of a prechilled (−20 • C) extraction solution (degassed acetonitrile:isopropanol:water at 3:3:2) with use of a GenoGrinder (Thomas Scientific), followed by centrifugation (14,000 × g for 2 min). The supernatant was collected and completely dried using a cold-trap vacuum concentrator (Labconco Centrivap). Dried samples were subsequently resuspended in 500 μL of a 50% aqueous acetonitrile solution and centrifuged (14,000 × g for 2 min) to remove membrane lipids and triglycerides. The sample was concentrated and derivatized (26) and then 1 μL of internal markers (C8-C30 fatty acid methyl esters) were added. The derivatized sample was injected for GC time-of-flight MS analysis as previously described (27) . All samples were analyzed in a single batch. The raw spectral data were first processed using Leco ChromaTOF software (v.2.32) for peak identification and mass spectra deconvolution. The spectral data were further refined using the BinBase algorithm (28) . All metabolite spectra in BinBase were matched against the Fiehn mass spectral library and the NIST spectral library based on the retention index and mass spectrum. The identified metabolites were reported for compound names and signal intensity of peak height (counts per spectrum).
Gene expression analysis
RNA extraction, cDNA synthesis, and real-time PCR were performed as described by Ji et al. (21) in accordance with the Minimum Information for Publication of Quantitative Real-Time PCR Experiments general guidelines (29) . Primers of the target genes encoding xanthine dehydrogenase (XDH), adenylosuccinate lyase (ADSL), hypoxanthine phosphoribosyltransferase 1 (HPRT1) and purine nucleoside phosphorylase (PNP) were designed using the National Center for Biotechnology Information Primer-BLAST tool. To prevent amplification of genomic DNA, primers were designed to span at least 1 exon-exon junction and were validated for single amplification and free of primer dimer (primer sequences are listed in Supplemental Table 1 ). Real-time PCR was run by QuantStudio 3 (Applied Systems). The expression of target genes was normalized against a reference gene, ribosomal protein L4. The relative expression was determined by the comparative cycle threshold (Ct) method (30) and presented as fold change relative to NI.
Immunoblot for protein expression
The protein expression of XO in the liver and hippocampus and MBP expression in the hippocampus were analyzed using western blot following the same procedure as previously described (21) . Primary antibodies against XO (rabbit anti-pig, polyclonal, Abcam, ab233148) and MBP (mouse anti-human, monoclonal, Santa Cruz Biotechnology, sc-271524; validated for cross-reactivity with pig) were used in the current study. The total protein transferred to the membrane was determined and served as the loading control.
XO activity assay
Hippocampal and liver tissues (∼200 mg) were homogenized (PYREX 7724-3, Corning) in ice-cold radioimmunoprecipitation assay lysis buffer (Sigma) containing a 3% (v/v) protease inhibitor cocktail (Sigma) and centrifuged at 13,000 × g at 4 • C for 5 min. The supernatant was used for the analysis of XO activity using an XO fluorometric assay kit (Cayman Chemical). The activity of XO in test samples was calculated based on a standard curve and normalized by wet tissue weight.
Uric acid assay
Concentrations of uric acid in the hippocampus (supernatant prepared as previously described) and plasma collected on PD 21 were analyzed with a uric acid fluorometric assay (Cayman Chemical). The concentration of uric acid in the hippocampus was normalized by wet tissue weight.
Statistical and bioinformatics analysis
Statistical and bioinformatics analyses for identified and unidentified metabolites in each tissue were performed separately. The metabolomics data of peak intensity were subjected to natural-logarithmic transformation and autoscaling before a Student's t test that was performed using PROC MULTTEST of SAS (v. 9.4) with Benjamini-Hochberg adjustment for multiple tests. Significance was declared at P < 0.05 and the false discovery rate-adjusted P value (q value) < 0.2. Metabolites that were significantly impacted were uploaded to MetaboAnalyst (https://www.metaboanalyst.ca/) for pathway enrichment analysis and clustering analysis. To identify the predictors of metabolic difference, multivariate modeling including principal component analysis (PCA) and discriminant analysis based on a partial least squares regression (PLS-DA) were performed on the data set of identified metabolites from the hippocampus and liver through built-in R statistics in MetaboAnalyst. Score plots were generated to visualize the top 2 sources of variance. The model predictability of the PLS-DA was crossvalidated using permutation tests with 2000 iterations. The statistics of model performance were reported as Q 2 , R 2 Y , and the corresponding P value of the permutation tests. Data on gene expression, XO activity, and protein expression of MBP were analyzed using PROC MIXED in SAS (v9.4) with the statistical model including treatment as a fixed effect and pig nested in treatment as a random effect. The lipid peroxidation data originally published in Ji et al. (21) for the 4 groups were reanalyzed using data from the HI and NI groups only. The reanalysis was performed using the same PROC MIXED model as described above. Significance was declared at P < 0.05.
Results
Multivariate analysis highlighted the impact of iron loading on the hippocampal metabolomics profile For hippocampal metabolomics, the PCA revealed that the top 5 and top 2 principal components (PCs) explained 81.5% (data not shown) and 44.6% of the variance, respectively. Score plots based on PC1 (x-axis) and PC2 (y-axis) showed moderate separation between the NI and HI treatments ( Figure 1A) . A clearer separation by treatment was observed in the x-axial direction (PC1, 24.2% variance) in the score plot of the PLS-DA analysis, which confirmed the main effect of iron loading on hippocampal metabolism ( Figure 1B) . The high R 2 (0.99) and Q 2 (0.72) values suggested good fitting of data and model predictability. The PCA based on identified metabolites in the liver samples revealed that the top 5 and top 2 PCs explained 78% and 48% of the variance, respectively; however, the score plot for the top 2 PCs showed substantial overlap between the 2 treatments (data not shown). In addition, the PLS-DA for liver metabolomics yielded poor model predictability (Q 2 < 0, data not shown).
Iron excess alters hippocampal metabolome in nursing pigs 3 Univariate analysis revealed the enrichment of purine metabolism in the hippocampus Totals of 278 (127 identified, 151 unidentified) and 292 (108 identified, 184 unidentified) metabolites were detected in the liver and hippocampus (Supplemental Tables 2-5) . Fifteen identified metabolites in the hippocampus significantly differed between the NI and HI groups (P < 0.05; q < 0.2; Table 1 ). In comparison with NI, the excess iron increased 6 and decreased 9 metabolites in the hippocampus. It is noteworthy that 6 of the altered metabolites are involved in purine metabolism, including adenosine, AMP, inosine, guanosine, hypoxanthine, and xanthine. This was confirmed by pathway analysis, in which purine metabolism (6 hits, unadjusted P < 0.0001 and q = 0.0005) and β-alanine metabolism (3 hits, unadjusted P = 0.0005 and q = 0.018) stood out as being significantly affected (data not shown). A representative diagram of the purine metabolism pathway in the pig is shown in Supplemental Figure 1 . Based on the profile of altered hippocampal metabolites, piglets within the same treatment were grouped in closer clusters (Figure 2 ). This suggests a consistent effect of treatment on hippocampal metabolism. In contrast, there was no effect of treatment on any metabolite detected in the liver or any unidentified metabolite detected in the hippocampus (q > 0.2; Supplemental Tables 2-5) .
Excess iron enhanced XO in the hippocampus but not in the liver
Because of the enrichment of purine metabolites, we further analyzed the mRNA expression of genes for key enzymes participating in purine salvage (HPRT1 and ADSL) and degradation pathways [PNP and xanthine dehydrogenase (XDH)] in both the hippocampus and the liver. In addition, the protein content and enzyme activity of XO were determined in the hippocampus and liver, because it is the rate-controlling enzyme in purine catabolism. Excess iron significantly increased mRNA expression (P = 0.005; Figure 3A) as well as the enzyme activity of XO in the hippocampus (P = 0.012; Figure 3B ). Although we observed a trend toward increased mRNA expression of XO in the liver (P = 0.086; Figure  3C ), neither enzyme activity ( Figure 3D ) nor protein content ( Figure 3E ) of XDH in the liver was affected by hepatic iron overload (P > 0.10). Surprisingly, XO was undetectable in the hippocampus using a western blot. This might be partially ascribed to its considerably lower expression in the brain than in the liver. In humans, XO is abundantly expressed in the liver and intestine; however, minimal expression is detected in other tissues and organs (31) . In comparison with NI, HI increased ADSL expression in the liver (P = 0.017; Supplemental Figure  2A ). Excess iron did not affect mRNA expression of HPRT1, ADSL, or PNP in the hippocampus (P > 0.1; Figure 4 ).
Impact of excess iron on uric acid concentration in the hippocampus and plasma
In humans, XO catalyzes the oxidation of xanthine to uric acid, which is the end product of purine degradation. Unlike humans, pigs possess uricase activity that further converts uric acid to allantoin (32, 33) . Because allantoin is rapidly degraded in pigs (34), uric acid was measured as a marker for purine catabolism in the current study. In comparison with NI, excess iron tended to increase the concentration of uric acid in the hippocampus by 13.6% (P = 0.069, Figure 5A ), whereas plasma uric acid on PD21 did not differ between the NI and HI treatments (P > 0.1, Figure 5B ).
Excess iron increased lipid peroxidation in the hippocampus
Activation of XO contributes to production of ROS. Excess iron significantly increased hippocampal lipid peroxidation compared with the NI group (P = 0.018; Figure 6A ).
Excess iron reduced protein expression of MBP
Myelination depends on the maturation of preoligodendrocytes, a process that is particularly vulnerable to oxidative stress (35) . Hippocampal expression of MBP, which is a marker for mature oligodendrocytes, tended to be lower in the HI group compared with the NI group (P = 0.053; Figure 6B ).
Discussion
We previously reported that iron oversupplementation [HI, 50 mg/(d·kg body weight)] in suckling piglets resulted in iron overload that was prominent in the liver (542 compared with 13.8 μg/g wet tissue in HI and NI, respectively) and the hippocampus (6.4 compared with 4.8 μg/g wet tissue in HI and NI, respectively) (21). Although unsupplemented piglets (NI) displayed signs of iron deficiency (hemoglobin concentration = 85 g/L) at weaning, their hippocampal iron concentration at weaning was comparable to iron-replete piglets that received iron dextran injections (4.8 and 5.2 μg/g wet tissue for the NI and iron-replete groups, respectively) (21) . Surprisingly, piglets receiving the HI treatment displayed a behavioral phenotype that was indicative of a lack of discrimination with regard to social novelty, a social recognition deficit that was previously observed in a mouse model with dysfunctional pyramidal neurons in CA2 of the hippocampus (22) . Nevertheless, sociability was completely normal for all piglets regardless of the dose of iron supplementation.
Others have also reported that dietary iron overexposure
Iron excess alters hippocampal metabolome in nursing pigs 5 impaired hippocampal-related cognitive development in ironreplete infants and rat pups (15, 20) . The underlying mechanism
is not yet known but may hypothetically involve the prooxidative effects of excess iron and its interference with cellular metabolism. Despite undue iron accumulation in the liver (547 compared with 14 μg/g wet tissue in HI vs. NI), the hepatic metabolites remained unaffected. It should be noted that hepatic expression of ferritin heavy chain protein was substantially increased by iron loading (21) . Thus, it is plausible that ferritin, the iron storage protein, secured excess iron from redox cycling (21) . In contrast, ferritin heavy chain expression in the hippocampus remained unchanged in response to hippocampal iron overload (∼32% higher in HI compared with NI) (21) . Therefore, iron deposition in the hippocampus presumably enlarged the labile iron pool, which increased ROS production and interfered with cellular metabolism. This was supported by our findings of exaggerated lipid peroxidation and an altered metabolomic profile in the hippocampus of iron-overloaded piglets. Myo-inositol is an abundant metabolite in the central nervous system that functions as an organic osmolyte to maintain brain cell volume (36) . It also serves as the precursor of inositol phosphates, which are intracellular second messengers involved in neuronal signaling (37) . Autistic children were reported to have lower myo-inositol concentrations in the brain than healthy cohorts (38) , which suggests the importance of myo-inositol in normal brain function. Therefore, a reduction in myo-inositol may adversely affect hippocampal functions in iron-overloaded piglets. Seven of 15 hippocampal metabolites affected by iron loading were associated with purine and pyrimidine metabolism. Decreased AMP and adenosine indicated a compromised cellular energy status, which, in the mammalian brain, largely relies on the purine salvage pathway to restore adenine nucleotides (39, 40) . In concert with the reduction in AMP and adenosine, excess iron deposition decreased pantothenic acid and N-acetylaspartic acid (NAA) in the hippocampus. In the central nervous system, NAA is primarily synthesized in the mitochondria of neuronal cells (41, 42) and is tightly associated with energy metabolism. This was supported by observations that 1) the concentration of NAA was changed in parallel with the fluctuations of cellular ATP (43, 44) , and 2) inhibition of the mitochondrial respiratory chain simultaneously decreased NAA production (45) . Pantothenic acid is essential for the synthesis of coenzyme A, and thus it is also critical in energy metabolism. The reduction in NAA and pantothenic acid further supports our postulation that iron overload jeopardized energy production in the developing hippocampus.
In contrast to the reduction in AMP and adenosine, 5 metabolites (guanosine, inosine, hypoxanthine, xanthine, and β-alanine) in the purine and pyrimidine catabolic pathways were uniformly increased by hippocampal iron overload. Together, the changes indicate a shift in purine flux from the salvage pathway toward degradation. Because the recycling of adenine from purine catabolism is important for ATP synthesis in the brain, downregulation of the purine salvage pathway would impair cellular energy metabolism. Xanthine oxidoreductase controls the rate-limiting steps of purine degradation by catalyzing the irreversible oxidation of hypoxanthine to xanthine and xanthine to uric acid (46) . The mammalian form of this enzyme can interconvert between NAD-dependent dehydrogenase (XDH) and O 2 -dependent oxidase (XO). When oxygen serves as an electron acceptor, the reaction generates oxygen radicals and hydrogen peroxide, which, in the presence of labile iron, further enhance the formation of hydroxyl radicals and increase the risk of cellular oxidative damage. XO is also an iron-containing enzyme and is involved in irondependent lipid peroxidation (47) . However, the factors that regulate the activation of XO remain to be elucidated. Iron exposure via an i.p. injection or intratracheal instillation has been shown to enhance XO activity in the lungs of rats (48) . To our knowledge, we are the first to report that iron overload increases both mRNA expression and enzyme activity of XO in the hippocampus. Surprisingly, both the protein expression and enzyme activity of XO were unaffected by overt tissue iron loading in the liver, where XO is abundantly expressed. Specifically, the hepatic XO activity was nearly 10 times greater than in the hippocampus, whereas the mRNA abundance of XDH was approximately 32-fold higher in the liver than in the hippocampus (median Ct value in liver = 22 cycles, median Ct value in hippocampus = 27 cycles, data not shown). Similarly, in humans, the specific activity of XO was 4-9 times higher in the liver than in the cerebellum and cerebral cortex (31) . Taken together, our findings suggest that regulation of XO is tissuespecific, and hippocampal XO exerts a functional response to labile iron.
Enhanced XO activity predicts an increase in ROS production. As in the case of perinatal hypoxia-ischemia, delayed neuronal damage was attributed to XO-mediated ROS production. The administration of allopurinol, an XO inhibitor, exhibited neuroprotective effects and improved long-term neurodevelopment in animal studies and human infants (49) (50) (51) (52) (53) . In the current study, enhanced hippocampal XO activity in iron-overloaded piglets could exacerbate lipid peroxidation. Although pigs express uricase that degrades uric acid to allantoin, iron oversupplementation still increased uric acid in the hippocampus, which closely paralleled the increase in XO activity.
In both humans and pigs, brain development in the early postnatal period is characterized by rapid myelination, which is carried out by mature oligodendrocytes (54) (55) (56) (57) . Because of Iron excess alters hippocampal metabolome in nursing pigs 7 large amounts of cellular free iron and low glutathione (58) , oligodendrocyte precursor cells and mature oligodendrocytes are exceptionally susceptible to the toxic effects of ROS (35) and lipid peroxidation by-products such as 4-hydroxy-2-nonenal (59) (60) (61) . MBP is a well-accepted marker of mature oligodendrocytes (62) . Therefore, the significant reduction in MBP in response to hippocampal iron overload indicates that iron-overloaded pigs may have compromised myelination.
Using a nursing piglet model, the current study provides evidence suggesting that hippocampal iron overload shifted purine metabolism from recycling toward degradation. This effect is mediated, at least in part, by the activation of XO, which may serve as the nexus between cellular free iron and cellular energy metabolism and ROS production. Direct evidence that supports the causal link between cellular free iron and the activation of XO is warranted in future research.
Acknowledgments
The authors' responsibilities were as follows-PJ: designed and conducted the study, analyzed the samples, performed data analysis, and wrote the manuscript; EBN: was involved in experimental design and edited manuscript revision; ND: contributed to sample analysis and edited manuscript revision; BL: contributed to experimental design and edited manuscript revision; BT: contributed to data analysis and edited manuscript revision; PJ: has primary responsibility for the final content; and all authors: read and approved the final manuscript.
